Background The aim of this study was to systematically synthesise the global evidence on
the prevalence of persistent symptoms in a general post COVID-19 population. Methods A …

Importance Short-term and long-term persistent postacute sequelae of COVID-19 (PASC)
have not been systematically evaluated. The incidence and evolution of PASC are …

Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3
million deaths. While the majority of infected individuals recover, a significant proportion …

Importance Infection with COVID-19 has been associated with long-term symptoms, but the
frequency, variety, and severity of these complications are not well understood. Many …

The existence of a variety of symptoms with a duration beyond the acute phase of COVID-
19, is referred to as post-COVID syndrome (PCS). We aimed to report a series of patients …

The nature and extent of persistent neuropsychiatric symptoms after COVID-19 are not
established. To help inform mental health service planning in the pandemic recovery phase …

Scope The aim of these guidelines is to provide evidence-based recommendations for the
assessment and management of individuals with persistent symptoms after acute COVID-19 …

Some evidence suggests that diabetes may be a risk factor for the development of post-
acute sequelae of COVID-19 (PASC). Recent data also indicate that new-onset diabetes …

Purpose This systematic review was performed to identify all relevant health-related quality
of life (HRQoL) issues associated with COVID-19. Methods A systematic literature search …

We present a multivariate metaboty** approach to assess the functional recovery of
nonhospitalized COVID-19 patients and the possible biochemical sequelae of “Post-Acute …